JBG SMITH PROPERTIES (JBGS)

US46590V1008 - REIT

15.37  +0.31 (+2.06%)

Fundamental Rating

2

Taking everything into account, JBGS scores 2 out of 10 in our fundamental rating. JBGS was compared to 130 industry peers in the Diversified REITs industry. The financial health of JBGS is average, but there are quite some concerns on its profitability. JBGS is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year JBGS has reported negative net income.
JBGS had a positive operating cash flow in the past year.
In multiple years JBGS reported negative net income over the last 5 years.
Each year in the past 5 years JBGS had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -2.29%, JBGS is not doing good in the industry: 79.53% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -6.29%, JBGS is doing worse than 75.59% of the companies in the same industry.
JBGS has a Return On Invested Capital of 0.22%. This is amonst the worse of the industry: JBGS underperforms 89.76% of its industry peers.
Industry RankSector Rank
ROA -2.29%
ROE -6.29%
ROIC 0.22%
ROA(3y)-0.45%
ROA(5y)-0.28%
ROE(3y)-1.13%
ROE(5y)-0.71%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 2.52%, JBGS is doing worse than 90.55% of the companies in the same industry.
In the last couple of years the Operating Margin of JBGS has remained more or less at the same level.
Looking at the Gross Margin, with a value of 50.72%, JBGS is doing worse than 79.53% of the companies in the same industry.
In the last couple of years the Gross Margin of JBGS has remained more or less at the same level.
Industry RankSector Rank
OM 2.52%
PM (TTM) N/A
GM 50.72%
OM growth 3YN/A
OM growth 5Y-1.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.85%
GM growth 5Y-0.05%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JBGS is destroying value.
The number of shares outstanding for JBGS has been reduced compared to 1 year ago.
The number of shares outstanding for JBGS has been reduced compared to 5 years ago.
JBGS has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.15, we must say that JBGS is in the distress zone and has some risk of bankruptcy.
JBGS's Altman-Z score of 0.15 is on the low side compared to the rest of the industry. JBGS is outperformed by 74.02% of its industry peers.
A Debt/Equity ratio of 1.39 is on the high side and indicates that JBGS has dependencies on debt financing.
The Debt to Equity ratio of JBGS (1.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACC0.04
WACC5.25%

2.3 Liquidity

A Current Ratio of 2.24 indicates that JBGS has no problem at all paying its short term obligations.
JBGS's Current ratio of 2.24 is fine compared to the rest of the industry. JBGS outperforms 77.17% of its industry peers.
A Quick Ratio of 2.24 indicates that JBGS has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.24, JBGS is in the better half of the industry, outperforming 78.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24

1

3. Growth

3.1 Past

JBGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -139.13%.
Looking at the last year, JBGS shows a decrease in Revenue. The Revenue has decreased by -7.13% in the last year.
Measured over the past years, JBGS shows a decrease in Revenue. The Revenue has been decreasing by -1.27% on average per year.
EPS 1Y (TTM)-139.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.83%
Revenue 1Y (TTM)-7.13%
Revenue growth 3Y0.08%
Revenue growth 5Y-1.27%
Sales Q2Q%-5.77%

3.2 Future

JBGS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -61.67% yearly.
Based on estimates for the next years, JBGS will show a small growth in Revenue. The Revenue will grow by 2.61% on average per year.
EPS Next Y-108.78%
EPS Next 2Y-61.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.45%
Revenue Next 2Y2.61%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

JBGS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBGS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

62.99% of the companies in the same industry are cheaper than JBGS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.91

4.3 Compensation for Growth

JBGS's earnings are expected to decrease with -61.67% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-61.67%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.69%, JBGS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 15.23, JBGS has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, JBGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.69%

5.2 History

The dividend of JBGS has a limited annual growth rate of 0.08%.
JBGS has been paying a dividend for over 5 years, so it has already some track record.
JBGS has decreased its dividend recently.
Dividend Growth(5Y)0.08%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

The earnings of JBGS are negative and hence is the payout ratio. JBGS will probably not be able to sustain this dividend level.
DP-57.98%
EPS Next 2Y-61.67%
EPS Next 3YN/A

JBG SMITH PROPERTIES

NYSE:JBGS (1/15/2025, 11:08:03 AM)

15.37

+0.31 (+2.06%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)02-18 2025-02-18/amc
Inst Owners98.83%
Inst Owner Change0%
Ins Owners0.05%
Ins Owner Change-1.61%
Market Cap1.30B
Analysts42.5
Price Target15.81 (2.86%)
Short Float %7.55%
Short Ratio10.52
Dividend
Industry RankSector Rank
Dividend Yield 4.69%
Dividend Growth(5Y)0.08%
DP-57.98%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.9%
Min EPS beat(2)10.36%
Max EPS beat(2)35.44%
EPS beat(4)3
Avg EPS beat(4)5.49%
Min EPS beat(4)-71.57%
Max EPS beat(4)47.71%
EPS beat(8)5
Avg EPS beat(8)11.02%
EPS beat(12)7
Avg EPS beat(12)98%
EPS beat(16)10
Avg EPS beat(16)80.83%
Revenue beat(2)0
Avg Revenue beat(2)-9.35%
Min Revenue beat(2)-17.51%
Max Revenue beat(2)-1.2%
Revenue beat(4)1
Avg Revenue beat(4)-4.36%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)19.87%
Revenue beat(8)1
Avg Revenue beat(8)-7.52%
Revenue beat(12)1
Avg Revenue beat(12)-7.36%
Revenue beat(16)3
Avg Revenue beat(16)-2.37%
PT rev (1m)-8.82%
PT rev (3m)-8.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.58%
EPS NY rev (1m)0%
EPS NY rev (3m)2.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.3
P/FCF N/A
P/OCF 8.34
P/B 0.69
P/tB 0.71
EV/EBITDA 15.91
EPS(TTM)-1.1
EYN/A
EPS(NY)-1.67
Fwd EYN/A
FCF(TTM)-1.29
FCFYN/A
OCF(TTM)1.84
OCFY11.99%
SpS6.68
BVpS22.28
TBVpS21.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.29%
ROE -6.29%
ROCE 0.28%
ROIC 0.22%
ROICexc 0.23%
ROICexgc 0.23%
OM 2.52%
PM (TTM) N/A
GM 50.72%
FCFM N/A
ROA(3y)-0.45%
ROA(5y)-0.28%
ROE(3y)-1.13%
ROE(5y)-0.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-0.94%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.95%
OM growth 3YN/A
OM growth 5Y-1.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.85%
GM growth 5Y-0.05%
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Debt/EBITDA 11.11
Cap/Depr 119.11%
Cap/Sales 46.88%
Interest Coverage 0.13
Cash Conversion 65.89%
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 0.15
F-Score5
WACC5.25%
ROIC/WACC0.04
Cap/Depr(3y)167.49%
Cap/Depr(5y)193.72%
Cap/Sales(3y)61.11%
Cap/Sales(5y)67.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-139.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.83%
EPS Next Y-108.78%
EPS Next 2Y-61.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.13%
Revenue growth 3Y0.08%
Revenue growth 5Y-1.27%
Sales Q2Q%-5.77%
Revenue Next Year6.45%
Revenue Next 2Y2.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.92%
EBIT growth 3YN/A
EBIT growth 5Y-2.38%
EBIT Next Year507.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.6%
OCF growth 3Y2.76%
OCF growth 5Y-0.52%